Stochastic Modeling of Lymphocyte Kinetics Reveals Mechanistic Biomarkers post Cancer Chemoradiation

Radhe Mohan Speaker
Department of Radiation Physics, Division of Radiation Oncology
 
Yiqing Chen Co-Author
 
Ren-Yi Wang Co-Author
 
Steven Lin Co-Author
Division of Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX
 
Thursday, Aug 6: 9:50 AM - 10:05 AM
2769 
Contributed Papers 
Thomas M. Menino Convention & Exhibition Center 
Radiation therapy induces profound disruptions in lymphocyte homeostasis, yet prognostic assessment in clinical practice largely relies on simple summaries such as absolute lymphocyte count (ALC) nadirs, which overlook rich temporal information encoded in the full ALC trajectory during and after chemoradiation. We propose a stochastic modeling framework to quantitatively characterize patient-specific radiation-induced lymphocyte kinetics. Built on state-dependent multi-type branching processes and diffusion approximations, this two-phase mechanistic model captures treatment-driven cytotoxicity and post-treatment regenerative dynamics through distinct self-renewal, death, and egress rates. Application to longitudinal ALC data from esophageal cancer patients receiving chemoradiation shows the estimated individual-level kinetic parameters from ALC trajectories provide prognostic information beyond nadir-based metrics. These results highlight the proposed framework as a mechanistically interpretable modeling of radiation-induced lymphocyte kinetics with potential to inform risk stratification and treatment planning in radiation oncology.

Keywords

Stochastic modeling


Longitudinal data

Oncology

Radiation therapy

Survival analysis

Immune kinetics 

Main Sponsor

Biometrics Section